Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $395 Billion
  • Q1 2025

Artia Global Partners LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $395 Billion distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $78.4B, Soleno Therapeutics Inc with a value of $35.6B, Verona Pharma PLC with a value of $34.2B, Intra Cellular Therapies, Inc. with a value of $29B, and Insmed Inc with a value of $24.3B.

Examining the 13F form we can see an increase of $115B in the current position value, from $280B to 395B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $395 Billion
Healthcare: $342 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$207M
$948 Million 0.24% of portfolio
421,359
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $395 Billion
  • Prior Value $280 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 8 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email